Cited by

• Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors.

  Pu Q, Zhang H, Guo L, Cheng M, Doty AC, Ferguson H, Fradera X, Lesburg CA, McGowan MA, Miller JR, Geda P, Song X, Otte K, Sciammetta N, Solban N, Yu W, Sloman DL, Zhou H, Lammens A, Neumann L, Bennett DJ, Pasternak A, Han Y. Pu Q, et al. ACS Med Chem Lett. 2020 Jul 15;11(8):1548-1554. doi: 10.1021/acsmedchemlett.0c00195. eCollection 2020 Aug 13. ACS Med Chem Lett. 2020. PMID: 32832022 Free PMC article.
• Cancer nanomedicine meets immunotherapy: opportunities and challenges.

  Sun Q, Bai X, Sofias AM, van der Meel R, Ruiz-Hernandez E, Storm G, Hennink WE, De Geest B, Kiessling F, Yu HJ, Lammers T, Shi Y. Sun Q, et al. Acta Pharmacol Sin. 2020 Jul;41(7):954-958. doi: 10.1038/s41401-020-0448-9. Epub 2020 Jun 17. Acta Pharmacol Sin. 2020. PMID: 32555445 Free PMC article. Review.
• Single-cell sequencing reveals the immune microenvironment associated with gastric cancer.

  Huang G, Yuan C, Zhang C, Yang F, Tan Y, Chen D, Li H, Qian K. Huang G, et al. Genes Dis. 2024 Jan 26;12(1):101218. doi: 10.1016/j.gendis.2024.101218. eCollection 2025 Jan. Genes Dis. 2024. PMID: 39391750 Free PMC article. No abstract available.
• Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers.

  Eso Y, Shimizu T, Takeda H, Takai A, Marusawa H. Eso Y, et al. J Gastroenterol. 2020 Jan;55(1):15-26. doi: 10.1007/s00535-019-01620-7. Epub 2019 Sep 7. J Gastroenterol. 2020. PMID: 31494725 Free PMC article. Review.
• The efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer patients of different age groups: a meta-analysis.

  Zheng SY, Cui HJ, Duan H, Peng YM, Li Q, Sun CY, Zhang JY, Shen W, Zhang X, Tan K, Jiang X. Zheng SY, et al. Clin Transl Oncol. 2020 Jul;22(7):1146-1154. doi: 10.1007/s12094-019-02241-5. Epub 2019 Nov 20. Clin Transl Oncol. 2020. PMID: 31748961 Free PMC article.